← Evidence map

ArticleOncotarget2016

Plasma osteoprotegerin and breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Lovisa Odén et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

22 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 27893411